Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis

Completed · Phase 3

Conditions studied: Uveitis, Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate, Panuveitis

In brief

This open-label study is designed to evaluate the safety of suprachoroidally administered triamcinolone acetone injectable suspension, CLS-TA, in patients with non-infectious uveitis with and without macular edema.

Key facts

Study ID
NCT03097315
Run by
Clearside Biomedical, Inc.
People needed
38
Starts
2017-04-04
Expected to finish
2018-01-24
Last updated by the study team
2021-06-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.